U. Chetty

发表

Arm morbidity within a trial of mastectomy and either nodal sample with selective radiotherapy or axillary clearance

R. Aitken, M. Gaze, A. Rodger, 1989, The British journal of surgery.

Mammostrat® as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy

Hans Christian Pedersen, D. Ross, B. Ring, 2010, Breast Cancer Research.

Imprint cytology of axillary lymph nodes as an intraoperative diagnostic tool.

U. Chetty, J. Dixon, P. Lambah, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Mutations in Breast Cancer

H. J. Evans, U. Chetty, C. Steel, 2006 .

p53 mutations in breast cancer.

H. J. Evans, U. Chetty, C. Steel, 1992, Cancer research.

Axillary dissection in breast cancer

U. Chetty, J. Dixon, G. Royle, 1991, The Lancet.

pS2 is an independent factor of good prognosis in primary breast cancer.

R. Elton, U. Chetty, D. Carter, 1993, British Journal of Cancer.

Diabetes matters in primary care

R. Hawkins, U. Chetty, A. Forrest, 2002, International Journal of Integrated Care.

Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.

C. M. Steel, D. J. Porteous, D. Porteous, 1988, British Journal of Cancer.

Evidence for the multistep theory of carcinogenesis in human breast cancer

A. Thompson, U. Chetty, D. Carter, 1992 .

Epidermal growth factor receptors in intracranial and breast tumours: their clinical significance.

R. Prescott, R. Hawkins, U. Chetty, 1991, British Journal of Cancer.

The detection of breast implant rupture using ultrasound.

U. Chetty, A. Watson, J. Walsh, 1996, British journal of plastic surgery.

Proximity ligation assays for isoform‐specific Akt activation in breast cancer identify activated Akt1 as a driver of progression

G. Kerr, J. Bartlett, D. Cameron, 2012, The Journal of pathology.

The importance of interpectoral nodes in breast cancer.

U. Chetty, J. Dixon, V. Dobie, 1993, European journal of cancer.

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.

R. Elton, U. Chetty, C. Steel, 1998, British Journal of Cancer.

Patient satisfaction following insertion of silicone breast implants.

U. Chetty, A. Watson, A. Park, 1996, British journal of plastic surgery.

Reasons for non-entry of patients with DCIS of the breast into a randomised trial (EORTC 10853).

I. Fentiman, U. Chetty, B. V. van Geel, 1991, European journal of cancer.

Screening for morbidity following breast cancer

U. Chetty, F. Coutts, W. Jack, 2012 .

Recruitment to a prospective breast conservation trial: why are so few patients randomised?

A. Rodger, U. Chetty, W. Jack, 1990, BMJ.

Cutaneous malignant melanoma. Publicity, screening clinics and survival—the Edinburgh experience 1982–90

U. Chetty, J. Hunter, K. Mclaren, 1995, The British journal of dermatology.

Stereotaxic localisation and aspiration cytology of impalpable breast lesions.

A. Kirkpatrick, U. Chetty, D. Dent, 1989, Clinical radiology.

Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management.

A. Rodger, U. Chetty, A. Forrest, 1985, British medical journal.

A 10-year experience of tamoxifen as primary treatment of breast cancer in 100 elderly and frail patients.

A. Rodger, U. Chetty, J. Smyth, 1991, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12–21

U. Chetty, J. Dixon, C. Steel, 1994, The British journal of surgery.

Pathological features predictive of local recurrence after management by conservation of invasive breast cancer: importance of non-invasive carcinoma.

G. Kerr, A. Rodger, U. Chetty, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Mammography in the management of patients with small breast cancers

U. Chetty, J. Dixon, 1991, The British journal of surgery.

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.

U. Chetty, A. Forrest, P. Levack, 1989, British Journal of Cancer.

Silicone Gel‐Filled Breast Implants and Connective Tissue Diseases

U. Chetty, A. Watson, R. Black, 1998, Plastic and reconstructive surgery.

Excision biopsy of malignant melanoma by general practitioners in south east Scotland 1982-91.

U. Chetty, J. Hunter, R. Herd, 1992, BMJ.

Does local surgery have a role in the management of stage IV breast cancer?

U. Chetty, J. Dixon, A. Carmichael, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Are the lesions of duct ectasia sterile?

U. Chetty, J. M. Dixon, N. Bundred, 1985, The British journal of surgery.

PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.

R. Elton, U. Chetty, C. Steel, 1998, British Journal of Cancer.

Indications for primary tamoxifen therapy in elderly women with breast cancer

U. Chetty, K. Sangster, R. Hawkins, 1992, The British journal of surgery.

RELATION BETWEEN IMMUNOCYTOCHEMICAL ESTIMATION OF OESTROGEN RECEPTOR IN ELDERLY PATIENTS WITH PRIMARY BREAST CANCER AND RESPONSE TO TAMOXIFEN

R. Hawkins, U. Chetty, A. Forrest, 1989, The Lancet.

Introduction to sessions on guidelines and endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer. Introduction to Session 6

U. Chetty, G. Wishart, 2009, Breast Cancer Research.

Randomised study of axillary clearance versus four node sampling

R. Prescott, A. Rodger, U. Chetty, 2001 .

Outcome of surgery for non‐palpable mammographic abnormalities

A. Kirkpatrick, R. Aitken, U. Chetty, 1990, The British journal of surgery.

Assessment of surgical excision during breast conservation surgery by intraoperative two‐dimensional specimen radiology

R. Aitken, U. Chetty, J. Going, 1990, The British journal of surgery.

Fibroadenoma of the breast: A follow‐up of conservative management

U. Chetty, T. Anderson, S. Wilkinson, 1989, The British journal of surgery.

A randomized double blind-cross over trial of soya protein for the treatment of cyclical breast pain.

U. Chetty, K. Setchell, W. Miller, 2000, Breast.

A human tumor model

U. Chetty, A. Forrest, J. Smyth, 1986 .

The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer

D. Cameron, U. Chetty, J. Dixon, 1997, Breast Cancer Research and Treatment.

Attitudes of breast cancer professionals to conventional and telemedicine-delivered multidisciplinary breast meetings

R. Prescott, J. Brebner, U. Chetty, 2005, Journal of telemedicine and telecare.

Radiotherapy and/or Tamoxifen after conserving surgery for breast cancers of excellent prognosis: BASO II trial

I. Ellis, S. Pinder, U. Chetty, 2007 .

Authors' Reply

G. Kerr, J. Bartlett, D. Cameron, 2013, The Journal of pathology.

Locally advanced breast cancer: report of phase II study and subsequent phase III trial.

G. Kerr, A. Rodger, U. Chetty, 1992, British Journal of Cancer.

Axillary node sampling in breast cancer: an assessment of its efficacy

U. Chetty, J. Dixon, T. Anderson, 1998 .

117 O - Axillary node sampling in breast cancer: an assessment of its efficacy

U. Chetty, J. Dixon, P. Dillon, 1996 .

The differing predictive values of oestrogen receptor assays for large breast cancers.

R. Hawkins, U. Chetty, A. Forrest, 1992, Postgraduate medical journal.

Periductal mastitis and duct ectasia: Different conditions with different aetiologies

U. Chetty, T. Anderson, T. Anderson, 1996, The British journal of surgery.

0-6. Axillary surgery in patients with breast cancer being treated by breast conservation: a randomised trial of node sampling and axillary clearance

R. Prescott, U. Chetty, W. Jack, 1997 .

The impact of core-biopsy on pre-operative diagnosis rate of screen-detected breast cancers.

B. Muir, J. Lamb, A. Kirkpatrick, 1997, Clinical Radiology.

Assessment of the acceptability of conservative management of fibroadenoma of the breast

U. Chetty, J. Dixon, J. Walsh, 1996, The British journal of surgery.

Author's reply

U. Chetty, 2000 .

Silicone breast implants and breast cancer

U. Chetty, A. Watson, A. Park, 1998 .

GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients

G. Kerr, J. Bartlett, U. Chetty, 2012, Breast Cancer Research and Treatment.

Assessment of non‐palpable mammographic abnormalities: Comparison between screening and symptomatic clinics

A. Huggins, B. Muir, R. Aitken, 1992, The British journal of surgery.

High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.

H. Gabra, D. Cameron, U. Chetty, 1996, British Journal of Cancer.

Primary treatment in breast cancer.

U. Chetty, A. Forrest, E. Anderson, 1991, BMJ.

Diagnosis and treatment of granulomatous mastitis

U. Chetty, J. Dixon, A. Sim, 1995, The British journal of surgery.

Quadrantectomy for early breast cancer

A. Rodger, U. Chetty, J. Dixon, 1992, The British journal of surgery.

The BASO II trial of adjuvant radiotherapy. V. None and tamoxifen. V. None in small, node negative, grade I tumours

R. Blamey, U. Chetty, A. Mitchell, 2001 .

Genetic linkage analysis applied to unaffected women from families with breast cancer can discriminate high‐ from low‐risk individuals

U. Chetty, A. Carothers, D. Carter, 1993, The British journal of surgery.

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.

H. J. Evans, R. Hawkins, U. Chetty, 1990, British Journal of Cancer.

Desmoid Tumours Treated with Triphenylethylenes

Edinburgh Eh, U. Chetty, 1992 .

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization.

U. Chetty, U. Chetty, C. McDonald, 1993, Human pathology.

Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis

C. M. Steel, Y. Nakamura, U. Chetty, 1990, The Lancet.

Constitutional p53 mutation in a non-Li-Fraumeni cancer family.

H. J. Evans, U. Chetty, C. Steel, 1992, British Journal of Cancer.

Cyclic AMP binding proteins and prognosis in breast cancer.

R. Elton, U. Chetty, W. Miller, 1990, British Journal of Cancer.

Goblet cell carcinoid of the appendix.

U. Chetty, K. Blessing, H. Gilmour, 1990, Gut.

Expression of activated type I receptor tyrosine kinases in early breast cancer

G. Kerr, J. Bartlett, D. Cameron, 2012, Breast Cancer Research and Treatment.

TELEMAM: a cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making.

J A Brebner, I H Kunkler, R. Prescott, 2007, European journal of cancer.

Critical determination of the frequency of c-erbB-2 amplification in breast cancer.

U. Chetty, T. Anderson, A. Thompson, 1994, British Journal of Cancer.

p53 allele losses, mutations and expression in breast cancer and their relationship to clinico‐pathological parameters

H. J. Evans, U. Chetty, D. Carter, 1992, International journal of cancer.

The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy.

U. Chetty, A. Forrest, P. Levack, 1988, British Journal of Cancer.

EFFECTS OF IMMEDIATE BREAST RECONSTRUCTION ON PSYCHOSOCIAL MORBIDITY AFTER MASTECTOMY

U. Chetty, U. Chetty, C. Dean, 1983, The Lancet.

Experimental acute pancreatitis in the rat--a new model.

U. Chetty, T. Taylor, H. Gilmour, 1980, Gut.

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.

S. Duffy, R. Blamey, S. Pinder, 2013, European journal of cancer.

Explorer Mammostrat ( R ) as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy

D. Ross, B. Ring, G. Kerr, 2010 .

Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index

U. Chetty, W. Miller, W. Jack, 2002, British Journal of Cancer.

Comparative pathology of breast cancer in a randomised trial of screening.

A. Huggins, B. Muir, P. Donnan, 1991, British Journal of Cancer.

The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: A controlled randomized trial

R. Steele, U. Chetty, A. Forrest, 1985, The British journal of surgery.

Lower-axillary-node sampling in conjunction with local excision for breast cancer.

P. Forrest, R. Steele, U. Chetty, 1986, The New England journal of medicine.

Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?

U. Chetty, A. Forrest, P. Levack, 1990, British Journal of Cancer.

Mammostrat® as a tool to stratify patients at risk of recurrence during endocrine therapy.

D. Ross, B. Ring, G. Kerr, 2009 .

MIB-1 in relation to tumour response and survival in patients with breast cancer treated with primary systemic therapy

D. Cameron, U. Chetty, A. Forrest, 1999 .

Comparison of Breast Cancer-Related Lymphedema (Upper Limb Swelling) Prevalence Estimated Using Objective and Subjective Criteria and Relationship with Quality of Life

U. Chetty, M. Barber, F. Coutts, 2013, BioMed research international.

Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up.

G. Kerr, J. Bartlett, D. Cameron, 2012, International journal of radiation oncology, biology, physics.

Histological grading of invasive breast carcinoma – a simplification of existing methods in a large conservation series with long‐term follow‐up

John M S Bartlett, G. Kerr, U. Chetty, 2009, Histopathology.

The p160 ER co-regulators predict outcome in ER negative breast cancer

S. Hilsenbeck, G. Kerr, J. Bartlett, 2011, Breast Cancer Research and Treatment.

Transforming growth factor β1 is unlikely to mediate p53 abnormalities in breast cancer

U. Chetty, A. Thompson, C. Steel, 1995, The British journal of surgery.

Osteogenic sarcoma--a rare primary tumour of the breast.

B. Muir, A. Lumsden, U. Chetty, 1985, European Journal of Surgical Oncology.

Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer

U. Chetty, J. Dixon, P. Forouhi, 1995, The British journal of surgery.

Nipple oedema: an unusual presenting sign of non-Hodgkin's lymphoma.

U. Chetty, N. Bundred, B. Whitfield, 1985, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Subcuticular skin closure following minor breast biopsy: Prolene is superior to polydioxanone (PDS)

U. Chetty, R. Aitken, E. D. Anderson, 1989, Journal of the Royal College of Surgeons of Edinburgh.

Cervical intraepithelial neoplasia in patients with breast cancer: a cytological and colposcopic study.

U. Chetty, M. Colquhoun, M. Alloub, 1993, British Journal of Cancer.

Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial

R. Prescott, A. Rodger, U. Chetty, 2000, The British journal of surgery.

A Morbidity Screening Tool for identifying fatigue, pain, upper limb dysfunction and lymphedema after breast cancer treatment: a validity study.

U. Chetty, M. Barber, F. Coutts, 2014, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

25. Upper limb morbidity after treatment for breast cancer: A cross-sectional study of lymphedema and function

U. Chetty, M. Barber, F. Coutts, 2012 .

Arm morbidity after breast conservation and axillary therapy

G. Kerr, A. Rodger, U. Chetty, 1995 .

The Edinburgh randomized trial of axillary sampling or clearance after mastectomy

R. Steele, U. Chetty, H. Stewart, 1995, The British journal of surgery.

Pooled long‐term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node‐positive breast cancer

G. Kerr, A. Rodger, U. Chetty, 2016, The British journal of surgery.

Axillary surgery in breast cancer--is there still a debate?

I. Fentiman, U. Chetty, 1992, European Journal of Cancer.

COMPARATIVE PATHOLOGY OF PREVALENT AND INCIDENT CANCERS DETECTED BY BREAST SCREENING Edinburgh Breast Screening Project

A. Huggins, B. Muir, J. Lamb, 1986, The Lancet.

Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.

D. Cameron, U. Chetty, A. Forrest, 1997, British Journal of Cancer.

Localization and excision of occult breast lesions

J. Lamb, A. Kirkpatrick, U. Chetty, 1983, The British journal of surgery.

The H-ras oncogene product p21 and prognosis in human breast cancer

R. Elton, U. Chetty, J. Dixon, 2005, Breast Cancer Research and Treatment.

Side effects expected and experienced by women receiving chemotherapy for breast cancer.

S. Closs, A. Rodger, U. Chetty, 1991, BMJ.

A randomized prospective trial comparing the value of intravenous and preincisional cefamandole in reducing postoperative sepsis after operations upon the gastrointestinal tract.

S. Duffy, U. Chetty, J. Dixon, 1984, Surgery, gynecology & obstetrics.

Appraisal of breast reconstruction with the tissue expansion technique.

U. Chetty, A. Thompson, 1990, Journal of the Royal College of Surgeons of Edinburgh.

Operative aid to combined synchronous mastectomy and latissimus dorsi breast reconstruction.

U. Chetty, A. Forrest, S. Wilkinson, 1985, The Australian and New Zealand journal of surgery.

Mammillary fistula

U. Chetty, N. Bundred, J. M. Dixon, 1987, The British journal of surgery.

Wound infection after breast biopsy

U. Chetty, J. Dixon, A. Forrest, 1988, The British journal of surgery.

The clinical syndrome of mammary duct ectasia.

U. Chetty, J. Dixon, 1983, The British journal of surgery.

CYCLICAL BREAST PAIN — SOME OBSERVATIONS AND THE DIFFICULTIES IN TREATMENT

U. Chetty, A. Forrest, G. Raab, 1992, The British journal of clinical practice.

Primary systemic therapy for operable breast cancer.

U. Chetty, A. Forrest, T. Anderson, 1991, British Journal of Cancer.

Colour Doppler ultrasonography studies of benign and malignant breast lesions

U. Chetty, J. Walsh, D. Paterson, 1992, The British journal of surgery.

Aminoglutethimide and advanced breast cancer [proceedings].

R. Hawkins, U. Chetty, A. Forrest, 1980, Biochemical Society transactions.

Prospective evaluation of prognostic factors in operable breast cancer.

U. Chetty, W. Miller, W. Jack, 1996, British Journal of Cancer.

A HUMAN TUMOUR MODEL

U. Chetty, A. Forrest, J. Smyth, 1986, The Lancet.

Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatment

U. Chetty, T. Anderson, P. Forouhi, 1994, The British journal of surgery.

The activity of locally applied cytotoxics to breast cancer cells in vitro.

U. Chetty, W. Miller, W. Scott, 1991, Annals of the Royal College of Surgeons of England.

Mitozantrone and prednimustine in the treatment of advanced breast cancer — a toxic regimen with low activity

D. Eccles, A. Rodger, U. Chetty, 2004, Cancer Chemotherapy and Pharmacology.

WHO NEEDS STEROID RECEPTOR ASSAYS?

U. Chetty, A. Forrest, T. Benraad, 1989, The Lancet.

Colour Doppler studies of axillary node metastases in breast carcinoma.

U. Chetty, J. Dixon, J. Walsh, 1994, Clinical radiology.

Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer

R. Elton, U. Chetty, W. Miller, 2004, Breast Cancer Research and Treatment.

Benign breast disease and cancer

C. C. Wang, U. Chetty, M. Roberts, 1980, The British journal of surgery.

A comprehensive approach for evaluating telemedicine-delivered multidisciplinary breast cancer meetings in southern Scotland

I H Kunkler, J Cairns, R. Prescott, 2005, Journal of telemedicine and telecare.

Spontaneous rupture of intrahepatic bile ducts.

U. Chetty, T. Taylor, J. Gollock, 1983, Journal of the Royal College of Surgeons of Edinburgh.

Edinburgh trial of screening for breast cancer: mortality at seven years

A. Huggins, B. Muir, P. Donnan, 1990, The Lancet.

Tamoxifen and mastectomy for elderly patients with operable breast cancer.

R. Hawkins, U. Chetty, A. Forrest, 1988, BMJ.

Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.

D. Porteous, R. Hawkins, U. Chetty, 1988, British Journal of Cancer.

Prospective evaluation of prognostic factors in operable breast cancer

U. Chetty, W. Jack, J. Dixon, 2007 .

Assessment of the acceptability of conservative management of fibroadenoma of the breast

U. Chetty, J. Walsh, J. Lamb, 1996, The British journal of surgery.

Explorer Prospective evaluation of prognostic factors in operable breast cancer

R. Hawkins, U. Chetty, W. Jack, 2017 .

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.

U. Chetty, Raleigh W Hawkins, CM Steel, 1990, British Journal of Cancer.

Experimental acute pancreatitis in the rat--a new model.

U. Chetty, T. Taylor, H. Gilmour, 1980, Gut.

Group dynamics in telemedicine-delivered and standard multidisciplinary team meetings: results from the TELEMAM randomised trial

John Cairns, Ross Maclean, Guy Fielding, 2006 .

Prevalence and impacts of upper limb morbidity after treatment for breast cancer: a cross-sectional study of lymphedema and function.

U. Chetty, M. Barber, F. Coutts, 2013 .

Implications from long-term follow-up after breast-conserving therapy for patient selection and duration of follow-up: The Edinburgh experience

G. Kerr, J. Bartlett, U. Chetty, 2008 .